1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow MQ719: new trials by email Literature Review of MQ719 trials Research Report on MQ719
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer MQ719, Pembrolizumab - Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 56 | 2023-05-04 | 2026-08-12 |
Adenocarcinoma, Sebaceous (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Skin Appendage (1) · Carcinoma, Squamous Cell (1) · Hemangiosarcoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Paget Disease, Extramammary (1) · Sarcoma, Kaposi (1) · Skin Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)
Lara Dunn, MD (1)